This list is an analysis based on recent market events. It's not an investment recommendation.
About
Electronic Components
Electronic Technology
Wize Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the treatment of ophthalmic disorders. It has in-license rights to purchase, market, sell, and distribute LO2A for the treatment of dry eye syndrome (DES) and other ophthalmological illnesses, including Conjunctivochalasis and Sjögren's syndrome (Sjögren's) in the United States and other territories. The company is also conducting a Phase IV study for LO2A for DES in patients with Sjögren's. The company was formerly known as Star Night Technologies Ltd. and changed its name to Wize Pharma, Inc. in July 2015. Wize Pharma, Inc. was founded in 1982 and is headquartered in Hod Hasharon, Israel.
Show more...
CEO
Noam Danenberg
Employees
2
Country
Israel
Listings
0 Comments
Share your thoughts
FAQ
What is Wize Pharma stock price today?▼
The current price of WIZP is $0.96 USD — it has increased by +5.49% in the past 24 hours. Watch Wize Pharma stock price performance more closely on the chart.
What is Wize Pharma stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Wize Pharma stocks are traded under the ticker WIZP.
What is Wize Pharma market cap?▼
Today Wize Pharma has the market capitalization of 467.26M
What were Wize Pharma earnings last quarter?▼
WIZP earnings for the last quarter are -0.09 USD per share, whereas the estimation was 0 USD resulting in a -∞% surprise. The estimated earnings for the next quarter are N/A USD per share.
How many employees does Wize Pharma have?▼
As of April 02, 2026, the company has 2 employees.
In which sector is Wize Pharma located?▼
Wize Pharma operates in the Professional, Scientific, and Technical Services sector.
When did Wize Pharma complete a stock split?▼
Wize Pharma has not had any recent stock splits.
Where is Wize Pharma headquartered?▼
Wize Pharma is headquartered in 24 Hanagar St, Israel.